Tweet
I'm a graduate student in Bioinformatics at Boston University. I'm with the graduate partnership with NIH so I'm doing my thesis at the National Cancer Institute. I'm working on miRNA profiling in neuroblastoma samples using nextgen technology. I have Solexa data and our lab is getting a Solid machine to test out, so I'll have a lot more data coming.
-
Wes Beckstead
Predoctoral Fellow in Bioinformatics
Boston University Partnership with NIH
[email protected]
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM